1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Post COVID-19 Condition: new trials by email Literature Review of Post COVID-19 Condition trials Research Report on Post COVID-19 Condition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial Hyperbaric oxygen - Post-COVID-19 Syndrome, Post-COVID Syndrome | Phase 3 | Unknown | Erasmus Medical Center | 120 | 2024-10-01 | 2024-02-28 |
| Pycnogenol® in Post-COVID-19 Condition Pycnogenol®, Placebo - Post COVID-19 Condition, Long COVID | Phase 3 | Completed | University of Zurich | 153 | 2023-06-07 | 2026-04-29 |
Post-Acute COVID-19 Syndrome (2) · COVID-19 (1)
Chronic Disease (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Disease Attributes (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Pneumonia (2) · Pneumonia, Viral (2) · Post-Infectious Disorders (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2)
Hyperbaric Oxygenation (1) · pycnogenols (1)
Erasmus Medical Center (1) · University of Zurich (1)
Netherlands (1) · Switzerland (1)
Alexia Anagnostopoulos, MD (1) · Jahn S Fehr, Prof., MD (1)